May 3, 2024 | Laboratory UTCBS, Research
The LHF Espoir and Artistes Sportifs de Coeur associations presented a cheque to the biotherapy team to support its research project, which aims to administer mRNA to restore the expression of the missing protein in genetic diseases such as Microvillous Inclusion...
Apr 11, 2024 | Laboratory UTCBS, Research
The Biotherapy team, in collaboration with the Nanobiosciences and microsystems team of unit 8640 of the CNRS (P.A.S.T.E.U.R) of the Ecole Normale Supérieure, has just published an article in the Journal of the American Chemical Society on the intracellular...
Feb 22, 2024 | Laboratory UTCBS, Research
A disease is considered rare when it affects less than 1 in 2,000 people. There are around 7,000 such diseases, affecting 3 million people in France. But most of these diseases are still shrouded in secrecy: the cause of more than half of them is unknown, which...
Feb 9, 2024 | Laboratory UTCBS
A great first day at #HYBRID2024! This morning, after an introduction by Bruno Bonnel, General Secretary for #Investment, we had the privilege of exploring new generations of vectors for gene therapy, as well as genome-editing strategies using Crispr Cas9. The round...
Feb 7, 2024 | Laboratory UTCBS, Research
#Towards widespread access to messenger RNA (mRNA) vaccines! A licensing agreement between SATT Aquitaine and Nexbiome Therapeutics has been signed to exploit an innovative technology developed by a team from the I2M research laboratory (University of Bordeaux, CNRS,...
Dec 6, 2023 | Laboratory UTCBS, Research
At the SFNano congress in Montpellier, Pauline Chavrier, a second-year PhD student, wins the best poster award for her work on Evaluation of functionalized liposomes’ targeting efficiency by assessing in vitro uptake and in vivo biodistribution. Evaluation of...
